Influence of the glucocorticoid receptor on c-fos inducibility in activated ras-containing mouse lung cells

Molecular Carcinogenesis

Volumn 17, Issue 2, 1996, Pages 70-77

  Johnson, Todd A ^a   Li, Jia ^a   Beer, David G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

fos; Glucorticoid receptor; jun; Ki ras

Indexed keywords

GLUCOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, FOS; GENES, JUN; GENES, RAS; LUNG; MICE; RATS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

ANIMALIA;

EID: 0029833363     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199610)17:2<70::AID-MC3>3.0.CO;2-X     Document Type: Article

References (50)

1. Ballard PL. Hormones and long maturation. Monogr Endocrinol 28:24-193,1986.
2. Kauffman SL. Proliferation, growth, and differentiation of pulmonary epithelium in fetal mouse lung exposed transplacentally to dexamethasone. Lab Invest 37:497-501,1977.
3. Droms KA, Hanson LA, Malkinson AM, Beer DG. Altered dexamethasone responsiveness and loss of growth control in tumorigenic mouse lung cell lines. Int J Cancer 53:1017-1022,1993.
4. Laurie Pan YH, Nuzum EO, Hanson LA, Beer DG. Ki-ras activation and expression in transformed mouse lung cell lines. Mol Carcinog 3:279-286,1990.
5. Jonat C, Rahmsdorf HJ, Park KK, et al. Antitumor promotion and antiinflamation: Down-modulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell 62:1189-1204,1990.
6. Yang-Yen HF, Chambard JC, Sun YL, et al. Transcriptional interference between c-jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215,1990.
7. Schule R, Rangarajan P, Kliewer S, et al. Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 62:1217-1226,1990.
8. Touray M, Ryan F, Jaggi R, Martin F. Characterization of functional inhibition of the glucocorticoid receptor by fos/jun. Oncogene 6:1227-1234,1991.
9. Halazonetis TD, Georgopoulos K, Greenberg ME. c-jun dimerizes with itself and with c-fos, forming complexes of different DNA binding affinities. Cell 55:917-924,1988.
10. Sassone-Corsi P, Lamph WW, Kampe M, Verma IM. Fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell 54:553-560,1988.
11. Kerppola TK, Luk D, Curran T. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol Cell Biol 13:3782-3791,1993.
12. Konig H, Ponta H, Rahmsdorf HJ, Herrlich P. Interference between pathway-specific transcription factors: Glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBOJ 11:2241-2246,1992.
13. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 249:1266- 1272,1990.
14. Karin M, Angel P. The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129-157,1991.
15. Miller AD, Curran T, Verma IM. c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene. Cell 36:51-60,1984.
16. Suzuki T, Hashimoto Y, Okuno H, Sato H, Nishina H, Iba H. High-level expression of human c-jun gene causes cellular transformation of chicken embryo fibroblasts. Jpn J Cancer Res 82:58-64,1991.
17. Castellazzi M, Loiseau L, Piu F, Sergeant A. Chimeric c-jun containing an heterologous homodimerization domain transforms primary embryo fibroblasts. Oncogene 8:1149-1160,1993.
18. Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, jun/AP-1. Cell 55:875- 885,1988.
19. Schonthal A, Buscher M, Angel P, et al. The fos and jun/AP-1 proteins are involved in the downregulation of fos transcription. Oncogene 4:629-636,1989.
20. Smith GJ, Le Mesurier SM, de Montfort ML, Lykke AWJ. Development and characterization of type 2 pneumocyte-related cell lines from normal adult mouse lung. Pathology 16:401- 405,1984.
21. Li J, Beer DG. Effect of increased glucocorticoid responsiveness in transformed mouse lung cells. Mol Carcinog 13:135- 145,1995.
22. Li J, Beer DG. Ki-ras mRNA regulation in untransformed mouse lung cells. Mol Carcinog 8:193-201,1993.
23. Ryder K, Nathans D. Induction of protooncogene c-jun by serum growth factors. Proc Natl Acad Sci USA 85:8464- 8467,1988.
24. Hanson LA, Nuzum EO, Jones BC, Malkinson AM, Beer DG. Expression of the glucocorticoid receptor and Ki-ras genes in ure- than-induced mouse lung tumors and transformed cell lines. Exp Lung Res 17:371-387,1991.
25. Li J, Johnson TA, Hanson LA, Beer DG. Loss of glucocorticoid- dependent growth inhibition in transformed mouse lung cells. Mol Carcinog, in press.
26. Schonthal A, Herrlich P, Rahmsdorf HJ, Ponta H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54:325- 334,1988.
27. Angel P, Baumann I, Stein B, et al. 12-O-tetradecanolyphorbol- 13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 7:2256-2266,1987.
28. Kraft AS, Anderson WB, Cooper HL, Sando JJ. Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells. J Biol Chem 257:13193-13196,1982.
29. 2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem Biophys Res Commun 120:1053-1059,1984.
30. Jonat C, Stein B, Ponta H, Herrlich P, Rahmsdorf HJ. Positive and negative regulation of collagenase gene expression. Matrix 1(Suppl):145-155,1992.
31. Piechaczyk M, Blanchard JM. c-fos proto-oncogene regulation and function. Crit Rev Oncol Hematol 17:93-131,1994.
32. Buscher M, Rahmsdorf HJ, Litfin M, Karin M, Herrlich P. Activation of the c-fos gene by UV and phorbol ester: Different signal transduction pathways converge to the same enhancer element. Oncogene 3:301-311,1988.
33. Siegfried Z, Ziff EB. Transcriptional activation by serum, PDGF, and TPA through the c-fos DSE: Cell type specific requirements for induction. Oncogene 4:3-11,1989.
34. Karagianni N, Tsawdaroglou N. The c-fos serum response element (SRE) confers negative response to glucocorticoids. Oncogene 9:2327-2334,1994.
35. Konig H, Ponta H, Rahmsdorf U, et al. Autoregulation of fos: The dyad symmetry element as the major target of repression. EMBO J 8:2559-2566,1989.
36. Shaw PE, Frasch S, Nordheim A. Repression of c-fos transcription is mediated through p67SRF bound to the SRE. EMBO J 8:2567-2574,1989.
37. Gauthier-Rouviere C, Basset M, Lamb NJC, Fernandez A. Role of fos-AP-1 binding sequence (FAR) in the induction of c-fos expression by purified C-kinase and in c-fos down-regulation following serum induction. Oncogene 7:363-369,1992.
38. Fisch TM, Prywes R, Roeder RG. An AP-1 binding site in the c- fos gene can mediate induction by epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate. Mol Cell Biol 9:1327-1331,1989.
39. Janknecht R, Cahill MA, Nordheim A. Signal integration at the c- fos promoter. Carcinogenesis 16:443-450,1995.
40. Fisch TM, Prywes R, Simon MC, Roeder RG. Multiple sequence elements in the c-fos promoter mediate induction by cAMP. Genes Dev 3:198-211,1989.
41. Sheng M, Dougan ST, McFadden G, Greenberg ME. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol 8:2787-2796,1988.
42. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM. Induction of prolo-oncogenejun/AP-1 by serum and TPA. Nature 334:629- 631,1988.
43. Derijard B, Hibi M, Wu IH, et al. JNK1: A protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-jun activation domain. Cell 76:1025-1037,1994.
44. Westwick JK, Cox AD, Der CJ, et al. Oncogenic ras activates c-jun via a separate pathway from the activation of extracellular signal-regulated kinases. Proc Natl Acad Sci USA 91:6030- 6034,1994.
45. Khosravi-Far R, Der CJ. The ras signal transduction pathway. Cancer Metastasis Rev 13:67-89,1994.
46. Nose K, Itami M, Satake M, Ito Y, Kuroki T. Abolishment of c-fos inducibility in ras-transformed mouse osteoblast cell lines. Mol Carcinog 2:208-216,1989.
47. Lin AH, Groppi VE, Gorman RR. Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene. Mol Cell Biol 8:5052-5055,1988.
48. Colletta G, Cirafici AM, Consiglio E, Vecchio G. Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line. Oncogene Research 1:459-466,1987.
49. Gauthier-Rouviere C, Fernandez A, Lamb NJC. ras-induced c-fos expression and proliferation in living rat fibroblasts involved C- kinase activation and the serum response element pathway. EMBO J 9:171-180,1990.
50. Fukumoto Y, Kaibuchi K, Oku N, Hori Y, Takai Y. Activation of the c-fos serum response element by the activated c-Haras protein in a manner independent of protein kinase C and cAMP-dependent protein kinase. J Biol Chem 265:774- 780,1990.